跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
GAVISCON NAUSEA - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
GAVISCON NAUSEA
Authorized
STANDARD
GAVISCON NAUSEA
medtech products inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
b3ecf43d93beda08
Company
medtech products inc
Type
Standard
Approval Details
Approval Id
b3ecf43d93beda08
Drug Approval Canada Name
GAVISCON NAUSEA
Product Name
GAVISCON NAUSEA
Status
Marketed
Status Date
2020-02-24
Original Market Date
2020-02-24
Din
02490528
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
OTC
Ahfs
56:22.08
Atc Original
R06AA11 DIMENHYDRINATE
Atc Name
r 06 aa 11
Aig Number
0102747004
Company Name
medtech products inc
Company Address
660 White Plains Road, Tarrytown, New York, United States, 10591
Active Ingredients
DIMENHYDRINATE
50 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
b3ecf43d93beda08
Type
Standard
Back to Health Canada Approvals